BRPI0915876A2 - composto azol - Google Patents

composto azol

Info

Publication number: BRPI0915876A2
Authority: BR; Brazil
Prior art keywords: azole compound; azole; compound
Prior art date: 2008-07-14

Application number

BRPI0915876A

Other languages

English (en)

Inventor

Hiromasa Oka

Kiyohiro Samizu

Noriyuki Kawano

Ryosuke Munakata

Satoshi Aoki

Takahiro Ishii

Takashi Sugane

Original Assignee

Astellas Pharma Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-07-14

Filing date

2009-07-13

Publication date

2015-11-03

2009-07-13 Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc

2015-11-03 Publication of BRPI0915876A2 publication Critical patent/BRPI0915876A2/pt

2019-07-09 Publication of BRPI0915876B1 publication Critical patent/BRPI0915876B1/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

BRPI0915876-6A 2008-07-14 2009-07-13 Composto azol, composição farmacêutica e uso do dito composto para tratamento da dor neuropática BRPI0915876B1 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2008182251		2008-07-14
JP2008-182251		2008-07-14
PCT/JP2009/062680 WO2010007966A1 (ja)	2008-07-14	2009-07-13	アゾール化合物

Publications (2)

Publication Number	Publication Date
BRPI0915876A2 true BRPI0915876A2 (pt)	2015-11-03
BRPI0915876B1 BRPI0915876B1 (pt)	2019-07-09

Family

ID=41550369

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0915876-6A BRPI0915876B1 (pt)	2008-07-14	2009-07-13	Composto azol, composição farmacêutica e uso do dito composto para tratamento da dor neuropática

Country Status (21)

Country	Link
US (1)	US8207199B2 (pt)
EP (1)	EP2308869B1 (pt)
JP (1)	JP5423675B2 (pt)
KR (1)	KR101566051B1 (pt)
CN (1)	CN102099354B (pt)
AU (1)	AU2009273105B2 (pt)
BR (1)	BRPI0915876B1 (pt)
CA (1)	CA2730793C (pt)
CY (1)	CY1113439T1 (pt)
DK (1)	DK2308869T3 (pt)
ES (1)	ES2393245T3 (pt)
HR (1)	HRP20120969T1 (pt)
IL (1)	IL210226A (pt)
MX (1)	MX2011000415A (pt)
PL (1)	PL2308869T3 (pt)
PT (1)	PT2308869E (pt)
RU (1)	RU2493154C2 (pt)
SI (1)	SI2308869T1 (pt)
TW (1)	TWI434842B (pt)
WO (1)	WO2010007966A1 (pt)
ZA (1)	ZA201100139B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20130150346A1 (en)	2010-01-08	2013-06-13	Quest Ventures Ltd.	Use of FAAH Inhibitors for Treating Parkinson's Disease and Restless Legs Syndrome
WO2011123719A2 (en)	2010-03-31	2011-10-06	Ironwood Pharmaceuticals, Inc.	Use of faah inhibitors for treating abdominal, visceral and pelvic pain
TW201206440A (en) *	2010-04-28	2012-02-16	Astellas Pharma Inc	Prophylactic or therapeutic agent for diseases associated with pains in urinary organs
JP2013147430A (ja) *	2010-04-28	2013-08-01	Astellas Pharma Inc	夜間頻尿の予防又は治療剤
FR2974365B1 (fr) *	2011-04-20	2017-08-25	Centre Nat De La Rech Scient (C N R S)	1,2,3-triazoles 1,4-disubstituees, leurs procedes de preparation et leurs utilisations diagnostiques et therapeutiques
DE102012018115A1 (de)	2012-09-13	2014-03-13	Matthias Lehr	Aryl-N-(arylalkyl)carbamate als Hemmstoffe der Fatty Acid Amide Hydrolase
CN104837820A (zh) *	2012-10-02	2015-08-12	大日本住友制药株式会社	咪唑衍生物
DE102013016573A1 (de)	2013-10-04	2015-04-09	Matthias Lehr	1-Tetrazolylpropan-2-one als Inhibitoren von cytosolischer Phospholipase A2 und Fatty Acid Amide Hydrolase, insbesondere geeignet zur topischen Anwendung
CN106632260B (zh) *	2016-09-29	2019-04-26	上海天慈生物谷生物工程有限公司	一种小分子激酶抑制剂的制备方法
US11970486B2 (en)	2016-10-24	2024-04-30	Janssen Pharmaceutica Nv	Compounds and uses thereof
CN110392833A (zh)	2017-01-06	2019-10-29	优曼尼蒂治疗公司	治疗神经病症的方法
WO2019084157A1 (en) *	2017-10-24	2019-05-02	Yumanity Therapeutics, Inc.	COMPOUNDS AND USES THEREOF
CN107602550B (zh) *	2017-10-25	2018-10-23	磐安县宸熙工艺品有限公司	一种脂肪酰胺水解酶抑制剂及其制备方法
AU2019238326B2 (en)	2018-03-23	2025-03-06	Janssen Pharmaceutica Nv	Compounds and uses thereof
EP3784234A1 (en)	2018-04-25	2021-03-03	Yumanity Therapeutics, Inc.	Compounds and uses thereof
CN108912112A (zh) *	2018-08-14	2018-11-30	李敬敬	一种化合物、制备方法以及其在治疗疼痛中的应用
MA54829A (fr)	2019-01-24	2021-12-01	Yumanity Therapeutics Inc	Composés et leurs utilisations
EA202192047A1 (ru)	2019-11-13	2021-12-08	Юманити Терапьютикс, Инк.	Соединения и их применение

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0850222B1 (en) *	1996-06-29	2003-05-28	Samjin Pharmaceutical Co., Ltd.	Piperazine derivatives and process for the preparation thereof
KR20040068240A (ko)	2001-12-14	2004-07-30	노보 노르디스크 에이/에스	호르몬 민감성 리파아제의 활성을 감소시키기 위한 화합물및 그들의 사용
PL373970A1 (en)	2002-02-08	2005-09-19	Bristol-Myers Squibb Company	(oxime)carbamoyl fatty acid amide hydrolase inhibitors
WO2004033422A2 (en)	2002-10-07	2004-04-22	The Regents Of The University Of California	Modulation of anxiety through blockade of anandamide hydrolysis
FR2854633B1 (fr) *	2003-05-07	2005-06-24	Sanofi Synthelabo	Derives de piperidinyl-et piperazinyl-alkylcarbamates, leur preparation et leur application en therapeutique
GB0325956D0 (en)	2003-11-06	2003-12-10	Addex Pharmaceuticals Sa	Novel compounds
FR2866884B1 (fr)	2004-02-26	2007-08-31	Sanofi Synthelabo	Derives d'aryl-et d'heteroaryl-piperidinecarboxylates, leur preparation et leur application en therapeutique
TW200633990A (en) *	2004-11-18	2006-10-01	Takeda Pharmaceuticals Co	Amide compound
TW200640864A (en) *	2005-02-17	2006-12-01	Astellas Pharma Inc	Pyridyl non-aromatic nitrogenated heterocyclic-1-carboxylate ester derivative
GB2424955B (en)	2005-04-09	2008-07-16	Siemens Ag	Flow meter with conductive coating
GB0510139D0 (en)	2005-05-18	2005-06-22	Addex Pharmaceuticals Sa	Novel compounds B1
WO2007005510A1 (en)	2005-06-30	2007-01-11	Janssen Pharmaceutica N.V.	N-heteroarylpiperazinyl ureas as modulators of fatty acid amide hydrolase
EP1923388A4 (en) *	2005-08-12	2011-03-09	Takeda Pharmaceutical	BRAIN / NEURONAL CELL PROTECTIVE AGENT AND THERAPEUTIC AGENT FOR SLEEP DISORDERS

2009
- 2009-07-10 TW TW098123505A patent/TWI434842B/zh not_active IP Right Cessation
- 2009-07-13 EP EP09797891A patent/EP2308869B1/en active Active
- 2009-07-13 CN CN2009801277856A patent/CN102099354B/zh not_active Expired - Fee Related
- 2009-07-13 WO PCT/JP2009/062680 patent/WO2010007966A1/ja not_active Ceased
- 2009-07-13 PL PL09797891T patent/PL2308869T3/pl unknown
- 2009-07-13 AU AU2009273105A patent/AU2009273105B2/en not_active Ceased
- 2009-07-13 MX MX2011000415A patent/MX2011000415A/es active IP Right Grant
- 2009-07-13 KR KR1020117001096A patent/KR101566051B1/ko not_active Expired - Fee Related
- 2009-07-13 CA CA2730793A patent/CA2730793C/en not_active Expired - Fee Related
- 2009-07-13 SI SI200930389T patent/SI2308869T1/sl unknown
- 2009-07-13 US US13/054,057 patent/US8207199B2/en not_active Expired - Fee Related
- 2009-07-13 ES ES09797891T patent/ES2393245T3/es active Active
- 2009-07-13 RU RU2011105151/04A patent/RU2493154C2/ru active
- 2009-07-13 HR HRP20120969AT patent/HRP20120969T1/hr unknown
- 2009-07-13 PT PT97978910T patent/PT2308869E/pt unknown
- 2009-07-13 JP JP2010520857A patent/JP5423675B2/ja not_active Expired - Fee Related
- 2009-07-13 BR BRPI0915876-6A patent/BRPI0915876B1/pt not_active IP Right Cessation
- 2009-07-13 DK DK09797891.0T patent/DK2308869T3/da active
2010
- 2010-12-23 IL IL210226A patent/IL210226A/en not_active IP Right Cessation
2011
- 2011-01-05 ZA ZA2011/00139A patent/ZA201100139B/en unknown
2012
- 2012-12-03 CY CY20121101178T patent/CY1113439T1/el unknown

Also Published As

Publication number	Publication date
EP2308869A4 (en)	2011-07-27
CY1113439T1 (el)	2016-06-22
CN102099354B (zh)	2013-07-10
MX2011000415A (es)	2011-03-15
BRPI0915876B1 (pt)	2019-07-09
US8207199B2 (en)	2012-06-26
CA2730793A1 (en)	2010-01-21
RU2011105151A (ru)	2012-08-20
SI2308869T1 (sl)	2012-12-31
JP5423675B2 (ja)	2014-02-19
AU2009273105B2 (en)	2013-09-05
JPWO2010007966A1 (ja)	2012-01-05
PT2308869E (pt)	2012-12-06
DK2308869T3 (da)	2012-10-08
EP2308869B1 (en)	2012-09-19
EP2308869A1 (en)	2011-04-13
ZA201100139B (en)	2012-03-28
WO2010007966A1 (ja)	2010-01-21
KR101566051B1 (ko)	2015-11-04
HRP20120969T1 (hr)	2012-12-31
TW201014840A (en)	2010-04-16
KR20110038671A (ko)	2011-04-14
CA2730793C (en)	2014-12-30
AU2009273105A1 (en)	2010-01-21
CN102099354A (zh)	2011-06-15
TWI434842B (zh)	2014-04-21
PL2308869T3 (pl)	2013-02-28
RU2493154C2 (ru)	2013-09-20
ES2393245T3 (es)	2012-12-19
US20110118311A1 (en)	2011-05-19
IL210226A (en)	2014-07-31
IL210226A0 (en)	2011-03-31

Publication	Publication Date	Title
BRPI0915876A2 (pt)	2015-11-03	composto azol
EP2269990A4 (en)	2012-04-18	Heterocyclic compound
BRPI0914746A2 (pt)	2019-09-24	composições fungicidas
DK2288375T3 (da)	2012-05-21	Pegylerede insulin-lispro-forbindelser
BRPI0920707A2 (pt)	2015-12-29	compostos
DK2242759T3 (da)	2012-12-17	Forbindelser
BRPI0813500A2 (pt)	2015-01-06	Compostos antivirais
BRPI0907184A2 (pt)	2019-09-24	fungicidas
BRPI0906705A2 (pt)	2015-06-30	Composto heterocíclicos
BRPI0918602A2 (pt)	2015-12-15	composto (i)
DK2323972T3 (da)	2013-10-07	C7-fluor-substituerede tetracylinforbindelser
BRPI0811264A2 (pt)	2014-11-04	Compostos
DK2297162T3 (da)	2012-11-26	Forbindelser
DK2142533T3 (da)	2011-12-12	Imidazolidinonderivater
EP2210876A4 (en)	2012-02-01	HETEROCYCLIC CONNECTION
BRPI0814424A2 (pt)	2015-01-06	Compostos heterociclila
BRPI0809996A2 (pt)	2014-10-14	Compostos
EP2295406A4 (en)	2012-04-18	HETEROCYCLIC CONNECTION
EP2326181A4 (en)	2012-11-28	ANTIFUNGALS
BRPI0821315A2 (pt)	2019-09-24	compostos benzimidazol
HRP20150932T1 (xx)	2015-10-09	Heterocikliäśki spojevi
BRPI0916432A2 (pt)	2016-02-16	compostos
BRPI0923592A2 (pt)	2016-01-26	composto
BRPI0912716A2 (pt)	2015-10-13	composto.
EP2284159A4 (en)	2012-06-13	5-hydroxypyrimidine-4-carboxamide compound

Legal Events

Date	Code	Title	Description
2017-10-10	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2018-07-31	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
2018-12-26	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2019-06-18	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2019-07-09	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 13/07/2009, OBSERVADAS AS CONDICOES LEGAIS. (CO) 20 (VINTE) ANOS CONTADOS A PARTIR DE 13/07/2009, OBSERVADAS AS CONDICOES LEGAIS
2023-05-09	B21F	Lapse acc. art. 78, item iv - on non-payment of the annual fees in time	Free format text: REFERENTE A 14A ANUIDADE.
2023-08-29	B24J	Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)	Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2731 DE 09-05-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.